tiprankstipranks
GlycoMimetics (GLYC)
NASDAQ:GLYC

GlycoMimetics (GLYC) Similar Stocks

Compare
973 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
GlycoMimetics
$0.29
$19.45M
-89.97%
Sarepta Therapeutics
$106.28
$10.36B
88.29
-21.15%
13 Buy
1 Hold
1 Sell
Strong Buy
Fate Therapeutics
$1.42
$175.97M
-79.21%
3 Buy
2 Hold
0 Sell
Moderate Buy
Karyopharm Therapeutics
$0.60
$77.01M
-47.08%
4 Buy
0 Hold
0 Sell
Strong Buy
Xencor
$15.74
$1.11B
-34.66%
4 Buy
0 Hold
0 Sell
Strong Buy
Argenx Se
$644.48
$39.15B
61.14%
11 Buy
1 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GLYC
GlycoMimetics
0.29
-2.61
-90.00%
SRPT
Sarepta Therapeutics
106.28
-30.25
-22.16%
FATE
Fate Therapeutics
1.42
-5.54
-79.60%
KPTI
Karyopharm Therapeutics
0.60
-0.64
-51.61%
XNCR
Xencor
15.74
-8.73
-35.68%
ARGX
Argenx Se
644.48
234.96
57.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis